Company profile FGEN
After 39 days of this quarter the interest is at 50.0. Based on that we can calculate that during remaining 52 days it will total up to 117.0. FibroGen expected interest is significantly lower compared to same quarter last year (-40.3%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 112 | 225 100.9% QoQ | 228 1.3% QoQ | 241 5.7% QoQ |
| 2020 | 201 79.5% YoY -16.6% QoQ | 206 -8.4% YoY 2.5% QoQ | 172 -24.6% YoY -16.5% QoQ | 193 -19.9% YoY 12.2% QoQ |
| 2021 | 231 14.9% YoY 19.7% QoQ | 289 40.3% YoY 25.1% QoQ | 250 45.3% YoY -13.5% QoQ | 137 -29.0% YoY -45.2% QoQ |
| 2022 | 177 -23.4% YoY 29.2% QoQ | 168 -41.9% YoY -5.1% QoQ | 166 -33.6% YoY -1.2% QoQ | 194 41.6% YoY 16.9% QoQ |
| 2023 | 196 10.7% YoY 1.0% QoQ | 299 78.0% YoY 52.6% QoQ | 232 39.8% YoY -22.4% QoQ | 134 -30.9% YoY -42.2% QoQ |
| 2024 | 50 -74.5% YoY -62.7% QoQ | - | - | - |
The average 5 years interest of FibroGen was 15.71 per week. The last year interest of FibroGen compared to the last 5 years has changed by 1.34%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -8.35%.
After 39 days of this quarter the interest is at 111.0. Based on that we can calculate that during remaining 52 days it will total up to 259.0. Pamrevlumab expected interest is significantly higher compared to previous quarter (+547.5%) and same quarter last year (+564.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 3 | 43 1333.3% QoQ | 12 -72.1% QoQ | 30 150.0% QoQ |
| 2020 | 14 366.7% YoY -53.3% QoQ | 17 -60.5% YoY 21.4% QoQ | 19 58.3% YoY 11.8% QoQ | 41 36.7% YoY 115.8% QoQ |
| 2021 | 19 35.7% YoY -53.7% QoQ | 54 217.6% YoY 184.2% QoQ | 60 215.8% YoY 11.1% QoQ | 52 26.8% YoY -13.3% QoQ |
| 2022 | 17 -10.5% YoY -67.3% QoQ | 45 -16.7% YoY 164.7% QoQ | 48 -20.0% YoY 6.7% QoQ | 28 -46.2% YoY -41.7% QoQ |
| 2023 | 39 129.4% YoY 39.3% QoQ | 70 55.6% YoY 79.5% QoQ | 31 -35.4% YoY -55.7% QoQ | 40 42.9% YoY 29.0% QoQ |
| 2024 | 111 184.6% YoY 177.5% QoQ | - | - | - |
The average 5 years interest of Pamrevlumab was 3.04 per week. The last year interest of Pamrevlumab compared to the last 5 years has changed by 67.76%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 172.73%.
After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0. Roxadustat expected interest is significantly higher compared to same quarter last year (+70.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 12 | 18 50.0% QoQ | 35 94.4% QoQ | 49 40.0% QoQ |
| 2020 | 29 141.7% YoY -40.8% QoQ | 30 66.7% YoY 3.4% QoQ | 31 -11.4% YoY 3.3% QoQ | 53 8.2% YoY 71.0% QoQ |
| 2021 | 59 103.4% YoY 11.3% QoQ | 51 70.0% YoY -13.6% QoQ | 55 77.4% YoY 7.8% QoQ | 26 -50.9% YoY -52.7% QoQ |
| 2022 | 32 -45.8% YoY 23.1% QoQ | 24 -52.9% YoY -25.0% QoQ | 19 -65.5% YoY -20.8% QoQ | 152 484.6% YoY 700.0% QoQ |
| 2023 | 30 -6.2% YoY -80.3% QoQ | 47 95.8% YoY 56.7% QoQ | 107 463.2% YoY 127.7% QoQ | 39 -74.3% YoY -63.6% QoQ |
| 2024 | 22 -26.7% YoY -43.6% QoQ | - | - | - |
The average 5 years interest of Roxadustat was 3.52 per week. The last year interest of Roxadustat compared to the last 5 years has changed by 24.15%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 83.61%.
After 39 days of this quarter the interest is at 23.0. Based on that we can calculate that during remaining 52 days it will total up to 54.0. Idiopathic pulmonary fibrosis treatment expected interest is significantly lower compared to same quarter last year (-69.1%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 84 | 164 95.2% QoQ | 171 4.3% QoQ | 203 18.7% QoQ |
| 2020 | 55 -34.5% YoY -72.9% QoQ | 83 -49.4% YoY 50.9% QoQ | 104 -39.2% YoY 25.3% QoQ | 175 -13.8% YoY 68.3% QoQ |
| 2021 | 115 109.1% YoY -34.3% QoQ | 123 48.2% YoY 7.0% QoQ | 187 79.8% YoY 52.0% QoQ | 183 4.6% YoY -2.1% QoQ |
| 2022 | 201 74.8% YoY 9.8% QoQ | 166 35.0% YoY -17.4% QoQ | 75 -59.9% YoY -54.8% QoQ | 141 -23.0% YoY 88.0% QoQ |
| 2023 | 175 -12.9% YoY 24.1% QoQ | 184 10.8% YoY 5.1% QoQ | 42 -44.0% YoY -77.2% QoQ | 48 -66.0% YoY 14.3% QoQ |
| 2024 | 23 -86.9% YoY -52.1% QoQ | - | - | - |
The average 5 years interest of Idiopathic pulmonary fibrosis treatment was 10.35 per week. The last year interest of Idiopathic pulmonary fibrosis treatment compared to the last 5 years has changed by -42.03%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -51.42%.
After 34 days of this quarter the interest is at 179.0. Based on that we can calculate that during remaining 58 days it will total up to 484.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 0 |
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 395 inf% YoY inf% QoQ | 408 inf% YoY 3.3% QoQ |
| 2021 | 425 inf% YoY 4.2% QoQ | 432 inf% YoY 1.6% QoQ | 554 40.3% YoY 28.2% QoQ | 490 20.1% YoY -11.6% QoQ |
| 2022 | 457 7.5% YoY -6.7% QoQ | 534 23.6% YoY 16.8% QoQ | 465 -16.1% YoY -12.9% QoQ | 403 -17.8% YoY -13.3% QoQ |
| 2023 | 426 -6.8% YoY 5.7% QoQ | 497 -6.9% YoY 16.7% QoQ | 469 0.9% YoY -5.6% QoQ | 179 -55.6% YoY -61.8% QoQ |
The average 5 years interest of Pancreatic cancer treatment was 23.59 per week. The last year interest of Pancreatic cancer treatment compared to the last 5 years has changed by 48.79%. The interest for Pancreatic cancer treatment is trending. This didn't exist 5 years ago.
After 34 days of this quarter the interest is at 67.0. Based on that we can calculate that during remaining 58 days it will total up to 181.0. Duchenne muscular dystrophy treatment expected interest is significantly lower compared to same quarter last year (-45.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 283 |
| 2019 | 564 99.3% QoQ | 347 -38.5% QoQ | 256 -26.2% QoQ | 398 40.6% YoY 55.5% QoQ |
| 2020 | 295 -47.7% YoY -25.9% QoQ | 181 -47.8% YoY -38.6% QoQ | 212 -17.2% YoY 17.1% QoQ | 193 -51.5% YoY -9.0% QoQ |
| 2021 | 223 -24.4% YoY 15.5% QoQ | 191 5.5% YoY -14.3% QoQ | 155 -26.9% YoY -18.8% QoQ | 158 -18.1% YoY 1.9% QoQ |
| 2022 | 211 -5.4% YoY 33.5% QoQ | 288 50.8% YoY 36.5% QoQ | 62 -60.0% YoY -78.5% QoQ | 330 108.9% YoY 432.3% QoQ |
| 2023 | 278 31.8% YoY -15.8% QoQ | 267 -7.3% YoY -4.0% QoQ | 255 311.3% YoY -4.5% QoQ | 67 -79.7% YoY -73.7% QoQ |
The average 5 years interest of Duchenne muscular dystrophy treatment was 19.98 per week. The last year interest of Duchenne muscular dystrophy treatment compared to the last 5 years has changed by 6.96%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -29.12%.
After 39 days of this quarter the interest is at 130.0. Based on that we can calculate that during remaining 52 days it will total up to 303.0. Anemia in chronic kidney disease expected interest is significantly higher compared to previous quarter (+388.7%) and same quarter last year (+339.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 32 | 71 121.9% QoQ | 44 -38.0% QoQ | 51 15.9% QoQ |
| 2020 | 78 143.8% YoY 52.9% QoQ | 62 -12.7% YoY -20.5% QoQ | 46 4.5% YoY -25.8% QoQ | 51 0.0% YoY 10.9% QoQ |
| 2021 | 61 -21.8% YoY 19.6% QoQ | 88 41.9% YoY 44.3% QoQ | 77 67.4% YoY -12.5% QoQ | 46 -9.8% YoY -40.3% QoQ |
| 2022 | 47 -23.0% YoY 2.2% QoQ | 62 -29.5% YoY 31.9% QoQ | 74 -3.9% YoY 19.4% QoQ | 48 4.3% YoY -35.1% QoQ |
| 2023 | 69 46.8% YoY 43.8% QoQ | 71 14.5% YoY 2.9% QoQ | 57 -23.0% YoY -19.7% QoQ | 62 29.2% YoY 8.8% QoQ |
| 2024 | 130 88.4% YoY 109.7% QoQ | - | - | - |
The average 5 years interest of Anemia in chronic kidney disease was 5.08 per week. The last year interest of Anemia in chronic kidney disease compared to the last 5 years has changed by 35.43%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 52.89%.
There is not enough data for Anemia related to myelodysplastic syndromes to provide analysis
There is not enough data for Anemia related to myelodysplastic syndromes to provide correlation calculation
There is not enough data for Anemia related to myelodysplastic syndromes to provide analysis
After 39 days of this quarter the interest is at 48.0. Based on that we can calculate that during remaining 52 days it will total up to 112.0. FibroGen -stock -company expected interest is significantly lower compared to same quarter last year (-53.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 109 | 225 106.4% QoQ | 257 14.2% QoQ | 221 -14.0% QoQ |
| 2020 | 210 92.7% YoY -5.0% QoQ | 148 -34.2% YoY -29.5% QoQ | 169 -34.2% YoY 14.2% QoQ | 217 -1.8% YoY 28.4% QoQ |
| 2021 | 251 19.5% YoY 15.7% QoQ | 343 131.8% YoY 36.7% QoQ | 263 55.6% YoY -23.3% QoQ | 142 -34.6% YoY -46.0% QoQ |
| 2022 | 229 -8.8% YoY 61.3% QoQ | 176 -48.7% YoY -23.1% QoQ | 192 -27.0% YoY 9.1% QoQ | 201 41.5% YoY 4.7% QoQ |
| 2023 | 241 5.2% YoY 19.9% QoQ | 357 102.8% YoY 48.1% QoQ | 270 40.6% YoY -24.4% QoQ | 131 -34.8% YoY -51.5% QoQ |
| 2024 | 48 -80.1% YoY -63.4% QoQ | - | - | - |
The average 5 years interest of FibroGen -stock -company was 16.86 per week. The last year interest of FibroGen -stock -company compared to the last 5 years has changed by 6.05%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 2.05%.